COUCH Health publishes report to encourage patient engagement in the MedTech sector pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Archbishop is 'very proud' president of Pax Christi thetablet.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thetablet.co.uk Daily Mail and Mail on Sunday newspapers.
Pax Christi AGM - Remaining faithful to the peace movement indcatholicnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indcatholicnews.com Daily Mail and Mail on Sunday newspapers.
The Kew Gardens 50p coin so rare that it's worth more than £150 and others you may own dailystar.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailystar.co.uk Daily Mail and Mail on Sunday newspapers.
Leeds, UK, April 19, 2021 - 4D pharma plc (AIM: DDDD; NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces a collaboration with Parkinson s UK, a non-profit organization focused on advancing the understanding of Parkinson s disease and improving treatments, to establish a Patient Advisory Board. The Patient Advisory Board (PAB) will be comprised of people living with Parkinson s. Supported by Parkinson s UK, the PAB will provide valuable patient-centric perspective to 4D pharma as it continues to advance novel Live Biotherapeutics into the clinic to treat neurodegenerative conditions such as Parkinson s. The PAB will also focus on raising awareness of the issues people with Parkinson s face with current treatment options.